Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1874 1
2002 1
2003 2
2004 2
2005 3
2006 7
2007 5
2008 4
2009 8
2010 6
2011 11
2012 12
2013 13
2014 14
2015 14
2016 12
2017 16
2018 15
2019 9
2020 10
2021 7
2022 9
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
SHIP inhibition mediates select TREM2-induced microglial functions.
Ramakrishnan GS, Berry WL, Pacherille A, Kerr WG, Chisholm JD, Pedicone C, Humphrey MB. Ramakrishnan GS, et al. Among authors: berry wl. Mol Immunol. 2024 Apr 12;170:35-45. doi: 10.1016/j.molimm.2024.04.002. Online ahead of print. Mol Immunol. 2024. PMID: 38613944 Free article.
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer.
Fecteau RE, Koontz BF, Hoffman KE, Halabi S, Howard LE, Anand M, George DJ, Zhang T, Berry WR, Lee WR, Harrison MR, Corn PG, Armstrong AJ. Fecteau RE, et al. Among authors: berry wr. Prostate Cancer Prostatic Dis. 2024 Feb 22. doi: 10.1038/s41391-024-00811-5. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38388778
Pembrolizumab and Enzalutamide in Patients with Abiraterone Acetate-Pretreated Metastatic Castration-Resistant Prostate Cancer: Cohort C of the Phase 1b/2 KEYNOTE-365 Study.
Yu EY, Berry WR, Gurney H, Retz M, Conter HJ, Laguerre B, Fong PCC, Ferrario C, Todenhöfer T, Gravis G, Piulats JM, Emmenegger U, Shore ND, Romano E, Mourey L, Li XT, Poehlein CH, Schloss C, Appleman LJ, de Bono JS. Yu EY, et al. Among authors: berry wr. Eur Urol Oncol. 2023 Nov 6:S2588-9311(23)00224-9. doi: 10.1016/j.euo.2023.10.008. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37940446 Free article.
FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.
Castillo-Castrejon M, Sankofi BM, Murguia SJ, Udeme AA, Cen HH, Xia YH, Thomas NS, Berry WL, Jones KL, Richard VR, Zahedi RP, Borchers CH, Johnson JD, Wellberg EA. Castillo-Castrejon M, et al. Among authors: berry wl. Breast Cancer Res. 2023 Aug 22;25(1):99. doi: 10.1186/s13058-023-01699-0. Breast Cancer Res. 2023. PMID: 37608351 Free PMC article.
Defining re-implementation.
Moyal-Smith R, Etheridge JC, Karlage A, Sonnay Y, Yuan CT, Havens JM, Brindle ME, Berry W. Moyal-Smith R, et al. Among authors: berry w. Implement Sci Commun. 2023 Jun 5;4(1):60. doi: 10.1186/s43058-023-00440-4. Implement Sci Commun. 2023. PMID: 37277862 Free PMC article.
182 results